The group confirmed the negative correlation between 25-hydroxyvitamin D and PTH: more than third (35.3%) of the case series had secondary hyperparathyroidism, with significant higher prevalence among participants in the lowest 25-hydroxyvitamin D quartile compared to those in the highest quartile [21]. Here, PTH is linked to secondary hyperparathyroidism.